Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beaded filament structural protein 2 (BFSP2; also known as phakinin or CP49) is a lens-specific type VI intermediate filament protein critical for the development, transparency, and mechanical stability of the vertebrate ocular lens[1][2][3][4]. BFSP2 forms the beaded filament cytoskeleton in lens fiber cells by coassembling with filensin (BFSP1), a process essential for the correct packing and organization of differentiating fiber cells and for minimizing light scatter within the lens[2][3][6]. BFSP2 disruption, due to inherited mutations, results in aberrant fiber cell structure, compromised refractive architecture, increased light scatter, and cataract formation, commonly in pediatric or early adulthood onset[1][2][4]. The protein does not function as a receptor, enzyme, transporter, or druggable target but is necessary for cytoskeletal integrity in lens tissues. Currently, no drugs are known to target BFSP2 directly; its main clinical relevance is as a structural protein whose mutations provide a genetic risk biomarker for opacity-related lens diseases[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beaded filament structural protein 2 (BFSP2).